Trial record 1 of 7 for:    cerulean
Previous Study | Return to List | Next Study

CRLX101 Plus Bevacizumab in Advanced RCC

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2012 by Abramson Cancer Center of the University of Pennsylvania.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01625936
First received: June 20, 2012
Last updated: June 21, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2014
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)